Updated hourlyHourly refreshSat, Oct 24, 2026
Press Release Database
Recent press releases, indexed by topic.
In the wire
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Investors who purchased (OTCMKTS:ILLR) securities between October 16, 2024 and December 29, 2026 may be eligible to recover losses. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Triller securities between October 16, 2024 and December 29, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/triller-group-inc-illr-class_action_lawsuit. Triller Case Details The Complaint alleges that throughout the Class Period, Defendants made false ..
Oct 23 · 17:03·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Lead Plaintiff Deadline: December 15, 2026. Investors who purchased (NASDAQ:QBTS) securities between February 26, 2026 and August 25, 2026 may be eligible to recover losses. Bronstein, Gewirtz & Grossman, LLC ("BG&G"), a nationally recognized investor-rights law firm, announces that it has filed a securities class action lawsuit against D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company") and certain of its officers. The lawsuit, captioned , Case No. 5:26-cv-11953, was filed on October 15, 2026, in the United States District Court for the Northern District of California. The action seeks to ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ArriVent BioPharma, Inc. ("ArriVent" or "the Company") (NASDAQ:AVBP). Investors who purchased ArriVent securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/arrivent-biopharma-inc-avbp-investigation. ArriVent Investigation Details On October 6, 2026, ArriVent BioPharma, Inc. announced that its global Phase 3 FURVENT trial evaluating firmonertinib in previously untreated patients with EGFR exon 20 insertion-mutated non-small-cell lung cancer failed to meet its primary endpoint of progression-free survival. Previously, the Company had stated in ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ubiquiti Inc. ("Ubiquiti" or "the Company") (NYSE:UI). Investors who purchased Ubiquiti securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/ubiquiti-inc-ui-class_action_lawsuit. Ubiquiti Investigation Details The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors and if the Ubiquiti board breached its fiduciary duties to shareholders. What's Next for Ubiquiti Investors? If you are aware of any facts relating to this investigation ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pasqal Holding SA ("Pasqal" or "the Company") (NASDAQ:PSQL). Investors who purchased Pasqal securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/pasqal-holding-sa-psql-class_action_lawsuit. Pasqal Investigation Details On September 28, 2026, Pasqal Holding SA announced that it was terminating its participation in France's LSQUARE/PROQCIMA defense program following completion of the program's first phase. The Company stated that it would instead focus its collaboration with French public authorities on commercial applications. Following ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of La-Z-Boy Incorporated ("La-Z-Boy" or "the Company") (NYSE:LZB). Investors who purchased La-Z-Boy securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/la-z-boy-incorporated-lzb-class_action_lawsuit. La-Z-Boy Investigation Details On August 18, 2026, La-Z-Boy Incorporated reported disappointing first-quarter fiscal 2027 financial results, missing analysts' expectations for both revenue and earnings. The Company reported revenue of approximately $476 million and adjusted earnings of $0.43 per share, compared to analysts' expectations of approximat
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Lead Plaintiff Deadline: December 8, 2026. Investors who purchased (NYSE:MRP) securities between February 7, 2025 and October 2, 2026 may be eligible to recover losses. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Millrose securities between February 7, 2025 and October 2, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/millrose-properties-inc-mrp-class_action_lawsuit. Millrose Case Details The Complaint alleges that throughout ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE:CC) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/chemours-company-cc-class_action_lawsuit. Chemours Case Details The ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against The Ensign Group, Inc. (NASDAQ:ENSG) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ensign securities between February 10, 2022 and June 18, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/the-ensign-group-inc-ensg-class_action_lawsuit. Ensign ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Netcapital Inc. (NASDAQ:NCPL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Netcapital securities between December 15, 2021 and September 3, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/netcapital-inc-ncpl-class_action_lawsuit. Netcapital Case Details The ..
Oct 23 · 17:02·PR-Inside
Finance · Real Estate
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed on behalf of former Anywhere Real Estate Inc. ("Anywhere") (formerly trading as NYSE: HOUS) investors who acquired Compass, Inc. ("Compass" or the "Company") (NYSE:COMP) common stock in direct exchange for Anywhere securities pursuant to the S-4 registration statement, 424B3 prospectus, and related oral communications (collectively, with materials incorporated therein, the "Registration Statement" or "Offering Materials"), issued in connection with the January 2026 stock-for-stock exchange by which Compass acquired ..
Oct 23 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / October 23, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Duolingo, Inc. (NASDAQ:DUOL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Duolingo securities between May 2, 2025 and February 26, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/duolingo-inc-duol-class_action_lawsuit. Duolingo Case Details The ..
Oct 23 · 17:02·PR-Inside